Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability
(Q46619924)
scientific article published on 20 March 2008
scientific article published on 20 March 2008
Language: